nuaxia | Blog

nuaxia

6 days ago3 min read

Merck Expands AI Drug Discovery Push with $510m Protillion Partnership

nuaxia

Jun 203 min read

Vedana launches with $46M to chase the next wave of migraine innovation beyond CGRP therapies

nuaxia

Jun 184 min read

Medscape Cardiology Compensation Report 2026

nuaxia

Jun 183 min read

Jazz Amplifies Its Oncology Ambitions with $2.4bn+ AbCellera Antibody Partnership

nuaxia

Jun 164 min read

Interpreting the DDRB 2026 Pay Award: What the Workforce Data Is Really Signalling

nuaxia

Jun 152 min read

FDA backs Merck’s dual-pronged push in kidney cancer with Welireg–Keytruda combo approval

nuaxia

Jun 133 min read

KARL STORZ Secures FDA Clearance for RUBINA Lens, Expanding Fluorescence Imaging into Open Surgery

nuaxia

Jun 123 min read

Subtle Medical Expands AI Imaging Platform with FDA Clearance for CT Enhancement Software

dan73778

Jun 112 min read

Lilly Adds Another Alzheimer’s Bet With $1bn Push Into Amyloid Modulation

nuaxia

Jun 103 min read

GSK’s $10.6bn Nuvalent Deal Marks a Shift Back to Late-Stage Oncology Scale Plays

nuaxia

Jun 93 min read

Breaking the BTK Code: Roche Goes All-In on Degrader Strategy with $2.3B Nurix Deal

nuaxia

Jun 73 min read

Philips Takes Ultrasound Into the AI Workflow Era with FDA Clearance for Elevate Plus

nuaxia

Jun 64 min read

ResMed Acquires Noctrix Health for $340m to Expand Beyond Sleep Apnoea

dan73778

Jun 53 min read

Alnylam and Inceptive Launch $2B AI Partnership to Accelerate RNAi Drug Discovery

nuaxia

Jun 43 min read

Lilly and Ascidian Enter $1.9bn Partnership to Advance RNA Exon Editing in Monogenic Kidney Disease

nuaxia

Jun 34 min read

A Standing Ovation for a New Chapter in Pancreatic Cancer

nuaxia

Jun 22 min read

FDA Approves AstraZeneca’s Imfinzi Plus BCG for High-Risk Bladder Cancer

dan73778

May 302 min read

Innovent Biologics and Pfizer Form $10bn+ Oncology Alliance Across 12 Cancer Programs

nuaxia

May 303 min read

Eli Lilly Builds Infectious Disease Platform with Three-Acquisition Strategy

nuaxia

May 293 min read

Merck Expands AI Drug Discovery Push with $510m Protillion Partnership

Vedana launches with $46M to chase the next wave of migraine innovation beyond CGRP therapies

Medscape Cardiology Compensation Report 2026

Jazz Amplifies Its Oncology Ambitions with $2.4bn+ AbCellera Antibody Partnership

Interpreting the DDRB 2026 Pay Award: What the Workforce Data Is Really Signalling

FDA backs Merck’s dual-pronged push in kidney cancer with Welireg–Keytruda combo approval

KARL STORZ Secures FDA Clearance for RUBINA Lens, Expanding Fluorescence Imaging into Open Surgery

Subtle Medical Expands AI Imaging Platform with FDA Clearance for CT Enhancement Software

Lilly Adds Another Alzheimer’s Bet With $1bn Push Into Amyloid Modulation

GSK’s $10.6bn Nuvalent Deal Marks a Shift Back to Late-Stage Oncology Scale Plays

Breaking the BTK Code: Roche Goes All-In on Degrader Strategy with $2.3B Nurix Deal

Philips Takes Ultrasound Into the AI Workflow Era with FDA Clearance for Elevate Plus

ResMed Acquires Noctrix Health for $340m to Expand Beyond Sleep Apnoea

Alnylam and Inceptive Launch $2B AI Partnership to Accelerate RNAi Drug Discovery

Lilly and Ascidian Enter $1.9bn Partnership to Advance RNA Exon Editing in Monogenic Kidney Disease

A Standing Ovation for a New Chapter in Pancreatic Cancer

FDA Approves AstraZeneca’s Imfinzi Plus BCG for High-Risk Bladder Cancer

Innovent Biologics and Pfizer Form $10bn+ Oncology Alliance Across 12 Cancer Programs

Eli Lilly Builds Infectious Disease Platform with Three-Acquisition Strategy

Jardine Matheson Acquires I-MED Radiology Network in $2.4bn Healthcare Imaging Deal